Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on May 30, 2025
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
GlobeNewswire
·
May 30, 2025
REDWOOD CITY, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc., announced its name change today to better align with …
SunnyMining launches free cloud mining service, Bitcoin, XRP, DOGE holders can obtain stable passive income daily
GlobeNewswire
·
May 30, 2025
London, UK , May 30, 2025 (GLOBE NEWSWIRE) -- SunnyMining is revolutionizing the way crypto investors mine digital assets by offering a cutting-edge cloud mining platform accessible to users around the globe. Designed with simplicity and performance in …
CORRECTION: VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US$6.05 Per Share, Above Last Market Closing Price Under NASDAQ Rules
GlobeNewswire
·
May 30, 2025
LONDON, May 30, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) hereby issues a correction regarding its press release dated 28 May 2025, titled "VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private …
XDC Network Partners with Bitso Business to Power Cross-Border Payments from the U.S. to Mexico
GlobeNewswire
·
May 30, 2025
Mexico City, Mexico, May 30, 2025 (GLOBE NEWSWIRE) -- The XDC Network, a leading blockchain platform for real-world finance, is proud to announce a strategic partnership with Bitso Business - the B2B arm of Bitso that provides infrastructure for efficient …
Blue and Red BV Joins Forces with ScreenCom BV to Create Integrated Workspace Technology Leader
GlobeNewswire
·
May 30, 2025
AMSTERDAM, May 30, 2025 (GLOBE NEWSWIRE) -- Blue and Red BV, a specialist in digital signage and workspace management technology, today announced the successful completion of its strategic merger with ScreenCom BV, a leading provider of enterprise digital …
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire
·
May 30, 2025
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of …
BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All Ages
GlobeNewswire
·
May 30, 2025
RESEARCH TRIANGLE PARK, N.C., May 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new data which highlights the reduction in the percentage of days with hereditary angioedema (HAE) symptoms among young children …
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 30, 2025
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at …
Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
GlobeNewswire
·
May 30, 2025
FREDERICK, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first participant …
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
GlobeNewswire
·
May 30, 2025
Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the results of the HERIZON-BTC-01 clinical study $20 million milestone payment to be received from …
Aurora Mobile's GPTBots.ai Welcomes the Enhanced DeepSeek-R1-0528 Model to Power Enterprise AI Solutions
GlobeNewswire
·
May 30, 2025
SHENZHEN, China, May 30, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced the integration of newly updated …
ScreenCom BV Expands Digital Signage Ecosystem Through Strategic Merger with Blue and Red BV
GlobeNewswire
·
May 30, 2025
AMSTERDAM, May 30, 2025 (GLOBE NEWSWIRE) -- ScreenCom BV, a leading provider of enterprise digital signage solutions, today announced the successful completion of its merger with Blue and Red BV, a specialist in digital signage and workspace management …
Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025
GlobeNewswire
·
May 30, 2025
Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached plateau, with 34% (7/20) of patients still alive 80% of patients treated with …
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
GlobeNewswire
·
May 30, 2025
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided …
Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO
GlobeNewswire
·
May 30, 2025
L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO L’étude AERIFY-1 a atteint son objectif principal, à savoir une réduction statistiquement significative des exacerbations modérées ou sévères chez …
Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials
GlobeNewswire
·
May 30, 2025
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically meaningful benefit AERIFY-2, a second Phase 3 trial, did …
Quantum eMotion Announces Brokered LIFE Financing of C$6,000,000
GlobeNewswire
·
May 30, 2025
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Quantum eMotion Corp. (“QeM” or the “Corporation”) (TSX.V: QNC; OTCQB: QNCCF) is pleased to announce a best efforts brokered …
Miningcoop Launches One of the Top and Most Profitable Bitcoin & Dogecoin Cloud Mining Services with Instant Setup and Daily Earnings
GlobeNewswire
·
May 30, 2025
London, UK, May 29, 2025 (GLOBE NEWSWIRE) -- According to the latest April 2025 report by Statista, global Bitcoin mining revenue is expected to surpass $50 billion this year, setting a new all-time high. Rising energy costs, expensive mining hardware, and …